Cost of multiple sclerosis in the Czech Republic: the COMS study
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
PubMed
21965424
DOI
10.1177/1352458511424422
PII: 1352458511424422
Knihovny.cz E-zdroje
- MeSH
- absentérství MeSH
- ambulantní péče ekonomika MeSH
- analýza rozptylu MeSH
- časové faktory MeSH
- dospělí MeSH
- důchody MeSH
- ekonomické modely MeSH
- lidé středního věku MeSH
- lidé MeSH
- náklady na léky MeSH
- náklady na zdravotní péči * MeSH
- návštěvy v ordinaci ekonomika MeSH
- nemocnice - náklady MeSH
- osobní újma zaviněná nemocí MeSH
- pomůcky pro sebeobsluhu ekonomika MeSH
- posuzování pracovní neschopnosti MeSH
- pracovní neschopnost ekonomika MeSH
- prevalence MeSH
- příjem MeSH
- prognóza MeSH
- prospektivní studie MeSH
- retrospektivní studie MeSH
- rozdělení chí kvadrát MeSH
- roztroušená skleróza diagnóza ekonomika epidemiologie terapie MeSH
- služby domácí péče ekonomika MeSH
- stupeň závažnosti nemoci MeSH
- zaměstnanost ekonomika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
BACKGROUND: Information about cost of multiple sclerosis (MS) is available from a number of European countries, but no data from the Czech Republic have been published so far. OBJECTIVE: The objective of this study was to establish the cost of MS in the Czech Republic, overall and by level of disease severity. METHODS: Data on demographics, disease history, resource consumption and production losses were collected from 909 patients recruited in 7 MS centres in the Czech Republic. Annual costs were estimated in the societal perspective, using 2007 unit costs. To evaluate the relationship between disability and costs, patients were stratified into those with mild (67%), moderate (27%) and severe (10%) disability using the Expanded Disability Status Scale. RESULTS: Mean total annual costs per patient were €12,272, of which 51% were direct medical costs, 4% direct non-medical costs and 45% indirect costs. The average annual costs in patients with mild, moderate and severe disability amounted to €9905, €14,064 and €22,880, respectively. CONCLUSION: The total costs of MS in the Czech Republic are estimated at €208.6 million per year. Consistent with other studies, the costs increase significantly with the severity of MS.
Citace poskytuje Crossref.org
Real-Life Outcome in Multiple Sclerosis in the Czech Republic
The direct costs of multiple sclerosis-study in the Czech Republic
Cognitive clinico-radiological paradox in early stages of multiple sclerosis
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome